TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19

被引:3
|
作者
Pena, Eduardo [1 ]
Ahmed, Saeed [2 ,3 ]
机构
[1] VA Boston Healthcare Syst, Drug Dependence Treatment Ctr, Jamaica Plain, MA 02130 USA
[2] Boston Med Ctr, Boston, MA USA
[3] VA Boston Healthcare Syst, Boston, MA USA
关键词
Buprenorphine; naloxone; Covid-19; medication for opioid use disorder; methadone; MOUD; opioid treatment programs; OTPs; SAMHSA;
D O I
10.1111/add.15143
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:1978 / 1979
页数:2
相关论文
共 50 条
  • [41] Trajectories of alcohol use and symptoms of alcohol use disorder in the United States during the first 2 years of the COVID-19 pandemic
    Martinez, P.
    Li, L.
    Patterson, D.
    Munroe, C.
    Surace, A.
    Greenfield, T. K.
    Kerr, W. C.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 99 - 99
  • [42] Speculation from the United States in the time of COVID-19
    Thorsteinsdottir, Bjorg
    LAEKNABLADID, 2020, 106 (09): : 440 - 440
  • [43] Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018
    Goyal, Sonal
    Monsour, Michael
    Ko, Jean Y.
    Curtis, Kathryn M.
    Whiteman, Maura K.
    Coy, Kelsey C.
    Cox, Shanna
    Romero, Lisa
    CONTRACEPTION, 2023, 117 : 67 - 72
  • [44] Access to medication for opioid use disorder supported by telemedicine and healthcare coverage: A web-based survey during the COVID-19 pandemic
    Monnig, Mollie A.
    Clark, Samantha E.
    Padovano, Hayley Treloar
    Sokolovsky, Alexander W.
    Goodyear, Kimberly
    Ahluwalia, Jasjit S.
    Monti, Peter M.
    ADDICTIVE BEHAVIORS REPORTS, 2023, 18
  • [45] Evaluating Changes in Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder Before and During the COVID-19 Pandemic
    Nguyen, Anh
    Binswanger, Ingrid
    Narwaney, Komal
    Xu, Stanley
    McClure, David
    Rinehart, Deborah
    Glanz, Jason
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [46] A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19
    Lockard, Rachel
    Priest, Kelsey C.
    Gregg, Jessica
    Buchheit, Bradley M.
    SUBSTANCE ABUSE, 2022, 43 (01) : 1150 - 1157
  • [47] Pregnancy, Opioid Use Disorder and COVID-19: An Evaluation of Acute Care Presentations During a Pandemic
    Gill, Elizabeth
    Ghimire, Anupa D.
    Robinett, Derek A.
    Booth, James S.
    Walter, Lauren A.
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (03) : E172 - E176
  • [48] Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients
    Pandit, Prabhat Mani
    Bhatia, Gayatri
    Sarkar, Siddharth
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 119
  • [49] Payer Strategies to Ensure Access to Care for Individuals With Opioid Use Disorder During COVID-19
    Bachireddy, Chethan
    Terplan, Mishka
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (03): : 91 - 92
  • [50] Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers
    Sung, Minhee L.
    Black, Anne C.
    Blevins, Derek
    Henry, Brandy F.
    Cates-Wessel, Kathryn
    Dawes, Michael A.
    Drexler, Karen
    Hagle, Holly
    Molfenter, Todd
    Levin, Frances R.
    Becker, William C.
    Edelman, E. Jennifer
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (05) : 505 - 513